Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 15280 | 651 | 38.3 | 72% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | HERSHBERGER ASSAY | Author keyword | 56 | 76% | 6% | 39 |
| 2 | VINCLOZOLIN | Author keyword | 19 | 32% | 8% | 49 |
| 3 | NIPPLE RETENTION | Author keyword | 18 | 89% | 1% | 8 |
| 4 | ENDOCRINE SCREENING | Author keyword | 17 | 100% | 1% | 8 |
| 5 | ENHANCED OECD TEST GUIDELINE 407 | Author keyword | 15 | 82% | 1% | 9 |
| 6 | STYRENE DIMERS | Author keyword | 12 | 86% | 1% | 6 |
| 7 | ENHANCED TEST GUIDELINE 407 | Author keyword | 11 | 100% | 1% | 6 |
| 8 | UTEROTROPHIC ASSAY | Author keyword | 10 | 31% | 4% | 28 |
| 9 | STYRENE TRIMER | Author keyword | 9 | 64% | 1% | 9 |
| 10 | MDA KB2 | Author keyword | 9 | 83% | 1% | 5 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | HERSHBERGER ASSAY | 56 | 76% | 6% | 39 | Search HERSHBERGER+ASSAY | Search HERSHBERGER+ASSAY |
| 2 | VINCLOZOLIN | 19 | 32% | 8% | 49 | Search VINCLOZOLIN | Search VINCLOZOLIN |
| 3 | NIPPLE RETENTION | 18 | 89% | 1% | 8 | Search NIPPLE+RETENTION | Search NIPPLE+RETENTION |
| 4 | ENDOCRINE SCREENING | 17 | 100% | 1% | 8 | Search ENDOCRINE+SCREENING | Search ENDOCRINE+SCREENING |
| 5 | ENHANCED OECD TEST GUIDELINE 407 | 15 | 82% | 1% | 9 | Search ENHANCED+OECD+TEST+GUIDELINE+407 | Search ENHANCED+OECD+TEST+GUIDELINE+407 |
| 6 | STYRENE DIMERS | 12 | 86% | 1% | 6 | Search STYRENE+DIMERS | Search STYRENE+DIMERS |
| 7 | ENHANCED TEST GUIDELINE 407 | 11 | 100% | 1% | 6 | Search ENHANCED+TEST+GUIDELINE+407 | Search ENHANCED+TEST+GUIDELINE+407 |
| 8 | UTEROTROPHIC ASSAY | 10 | 31% | 4% | 28 | Search UTEROTROPHIC+ASSAY | Search UTEROTROPHIC+ASSAY |
| 9 | STYRENE TRIMER | 9 | 64% | 1% | 9 | Search STYRENE+TRIMER | Search STYRENE+TRIMER |
| 10 | MDA KB2 | 9 | 83% | 1% | 5 | Search MDA+KB2 | Search MDA+KB2 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | REPRODUCTIVE MALFORMATIONS | 46 | 75% | 5% | 33 |
| 2 | GUIDELINE NO 407 | 38 | 93% | 2% | 14 |
| 3 | METABOLIC MODULATORS | 26 | 80% | 2% | 16 |
| 4 | FUNGICIDE VINCLOZOLIN | 23 | 64% | 4% | 23 |
| 5 | ENVIRONMENTAL ANTIANDROGENS | 20 | 46% | 5% | 33 |
| 6 | I SCREENING BATTERY | 20 | 59% | 3% | 22 |
| 7 | FUNGICIDE PROCHLORAZ | 18 | 49% | 4% | 27 |
| 8 | DRAFT PROTOCOL | 17 | 79% | 2% | 11 |
| 9 | MALE RAT ASSAY | 17 | 100% | 1% | 8 |
| 10 | DOSE TOXICITY | 15 | 77% | 2% | 10 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Mode of action: Inhibition of androgen receptor function - Vinclozolin-induced malformations in reproductive development | 2005 | 27 | 22 | 68% |
| Relevance Weighting of Tier 1 Endocrine Screening Endpoints by Rank Order | 2014 | 2 | 95 | 28% |
| Disruption of androgen receptor signaling in males by environmental chemicals | 2011 | 38 | 124 | 18% |
| In vitro bioassays for androgens and their diagnostic applications | 2008 | 12 | 71 | 38% |
| Environmental Endocrine Disrupters | 2008 | 31 | 83 | 22% |
| The adrenal cortex and steroidogenesis as cellular and molecular targets for toxicity: Critical omissions from regulatory endocrine disrupter screening strategies for human health? | 2003 | 44 | 36 | 22% |
| Evaluation of Tier I screening approaches for detecting endocrine-active compounds (EACs) | 2002 | 30 | 95 | 31% |
| Adrenocortical hypertrophy: establishing cause and toxicological significance | 2010 | 8 | 28 | 18% |
| Adrenal toxicology: a strategy for assessment of functional toxicity to the adrenal cortex and steroiclogenesis | 2007 | 26 | 87 | 9% |
| Xenoestrogens: mechanisms of action and detection methods | 2004 | 45 | 70 | 11% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CHEM ASSESSMENT | 5 | 27% | 2.5% | 16 |
| 2 | ENDOCRINOL BRANCH | 5 | 23% | 2.9% | 19 |
| 3 | TOXICOL RISK ASSESSMENT | 5 | 14% | 4.8% | 31 |
| 4 | BUSINESS UNIT TOXICOL BIOASSAYS | 4 | 75% | 0.5% | 3 |
| 5 | RTDENDOCRINOL BRANCH | 3 | 100% | 0.5% | 3 |
| 6 | BSP GDD GED GTOX SPECIAL TOXICOL | 3 | 60% | 0.5% | 3 |
| 7 | ECOSCREEN RD SECT | 2 | 67% | 0.3% | 2 |
| 8 | ENDOCRINE DISRUPTING CHEM ANAL | 2 | 67% | 0.3% | 2 |
| 9 | BIOMED SCI TOXICOL | 1 | 50% | 0.3% | 2 |
| 10 | ENDOCRINE TOXICOL TEAM | 1 | 50% | 0.3% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000240889 | METHOXYCHLOR//HPTE//IMMUNOTOXICOL ACUTE TOXICOL |
| 2 | 0.0000175046 | CONAZOLES//ZEBRAFISH EMBRYOTOXICITY TEST//TRIADIMEFON |
| 3 | 0.0000143342 | ATRAZINE//CHLOROTRIAZINES//DIAMINOCHLOROTRIAZINE |
| 4 | 0.0000141997 | 17 ALPHA ETHINYLESTRADIOL//ENDOCRINE DISRUPTION//VITELLOGENIN |
| 5 | 0.0000140648 | HYPOSPADIAS//STUDY TREATMENT HYPOSPADIAS//GENITAL TUBERCLE |
| 6 | 0.0000104738 | COMPUTAT TOXICOL//ALTERNAT ANIM TESTING//ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION |
| 7 | 0.0000101125 | DIIODOMETHYL P TOLYLSULFONE//THYROID CARCINOGENESIS//AMICAL |
| 8 | 0.0000098015 | BISPHENOL A//BPA//BISPHENOL A BPA |
| 9 | 0.0000097506 | EXPERIMENTAL ORAL CANCER//ROMAN HIGH AVOIDANCE//ROMAN LOW AVOIDANCE |
| 10 | 0.0000095050 | SERAMS//MATH CHEM//ESTROGEN RECEPTOR LIGANDS |